We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Dentistry Approaching a Major New Treatment Breakthrough

By HospiMedica International staff writers
Posted on 13 Jul 2010
The next big treatment revolution in dentistry could involve a novel regenerative therapy in which diseased or necrotic pulp tissues are replaced with healthy pulp tissue to revitalize teeth, claims a new study.

Researchers at the Institut National de la Sante et de la Recherche Medicale (INSERM; Strasbourg, France), the University of Montpellier (France), and other institutions reported the development of a multilayered, nano-sized film--only 1/50,000th the thickness of a human hair--that contains alpha melanocyte stimulating hormone (α-MSH), a substance that possesses anti-inflammatory properties in many acute and chronic inflammatory models. More...
When α-MSH was covalently coupled to poly-l-glutamic acid (PGA), the resulting PGA-α-MSH nanofilm retained its anti-inflammatory properties when tested on rat monocytes.

The researchers then incubated PGA-α-MSH with dental pulp lipopolysaccharide (LPS)-stimulated fibroblasts, and were able to show that PGA-α-MSH has potential effects in promoting human pulp fibroblast adhesion and cell proliferation. It can also reduce the inflammatory state of LPS-stimulated pulp fibroblasts, as observed in gram-negative bacterial infections. According to the researchers, these effects suggest a novel use of PGA-α-MSH as an anti-inflammatory agent in regenerative endodontics, the development and delivery of tissues to replace diseased or damaged dental pulp, and could provide a revolutionary alternative to pulp removal in root canal therapy (RCT). The study was reported in the July 2010 issue of the American Chemical Society (ACS) journal Nano.

"It's not like toothpaste, which prevents cavities,” said coauthor Nadia Benkirane-Jessel, Ph.D., of INSERM. "Here we are really trying to control cavities after they develop. Instead of a drill, a quick dab of gel or a thin film against an infected tooth could heal teeth from within.”

According to the researchers, PGA-α-MSH can not only modulate pro- and anti-inflammatory cytokines but can also promote adhesion of pulpal fibroblasts, and could therefore have important regulatory functions in extracellular matrix composition, as well as additional regulatory functions needed to modulate pulpal inflammation and reduce the need for RCT.

Related Links:

Institut National de la Sante et de la Recherche Medicale
University of Montpellier




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.